News
WASHINGTON (AP) — Few U.S. adults support allowing religious schools to become tax-funded public charter schools, but a ...
The latest roster also saw the return of midfielder Rose Lavelle, who hasn’t played for the United States in more than six ...
With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...
Shares in biopharmaceutical company Viking Therapeutics (NASDAQ: VKTX) were up by 6.3% at 12:30 a.m. ET today. The move ...
Success camp returned to the University of Indianapolis campus this week to encourage high-schoolers to spend some time both ...
Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.
India's drug regulator on Thursday approved the launch of pre-filled injector pens of Eli Lilly's blockbuster weight-loss drug, Mounjaro, giving the company more options to compete with rival Novo ...
The UK's health regulator is investigating Ozempic and Mounjaro after linking the drugs to hundreds of severe illnesses and ...
History's first American pope reaffirmed Wednesday that the primary role of bishops is to forge unity in his diocese among ...
Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients ...
Mounjaro is one of the bestselling weight loss drugs. See what your options are if you want to invest in Mounjaro stock.
There are growing concerns about the side effects caused by weight loss injections such as Ozempic, Wegovy and Mounjaro.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results